E1	Condition:T1 Name:T27
E2	Condition:T2 Name:T28
E3	Condition:T3 Name:T29
E4	Assertion:T4 Asserted:E5
E5	Drug:T5 Stability:T30
E7	Study:T7 
E8	Eq-Comparison:T8 Temporal-Period:T31
E9	Condition:T9 Name:T32 Temporality:E8
E10	Condition:T10 Name:T33
E11	Exception:T11 From:E10 Except:E12
E12	Condition:T12 Name:T34
E13	Procedure:T13 
E14	Study:T14 Study-Of:E15
E15	Drug:T15 Temporality:E16
E16	Eq-Comparison:T16 Operator:T35 Value:T36 Temporal-Unit:T37
E18	Study:T18 
E19	Encounter:T19 
E20	Eq-Comparison:T20 Operator:T39 Value:T40 Temporal-Unit:T41
E22	Study:T22 
E23	Condition:T23 Severity:T42
E24	Condition:T24 Name:T43
E26	Condition:T26 Name:T44
T1	Condition 115 118	PMM
T2	Condition 187 209	mitochondrial mutation
T3	Condition 227 235	myopathy
T4	Assertion 241 248	Able to
T5	Drug 266 276	medication
T7	Study 292 297	study
T8	Eq-Comparison 346 353	ongoing
T9	Condition 354 368	rhabdomyolysis
T10	Condition 388 407	motor abnormalities
T11	Exception 408 418	other than
T12	Condition 430 451	mitochondrial disease
T13	Procedure 457 466	Treatment
T14	Study 475 490	investigational
T15	Drug 491 495	drug
T16	Eq-Comparison 496 511	within 3 months
T18	Study 521 524	Day
T19	Encounter 532 544	Hospitalised
T20	Eq-Comparison 545 560	within 3 months
T22	Study 570 579	screening
T23	Condition 594 611	medical condition
T24	Condition 617 625	Pregnant
T26	Condition 629 636	nursing
T27	Condition-Name 115 118	PMM
T28	Condition-Name 187 209	mitochondrial mutation
T29	Condition-Name 227 235	myopathy
T30	Stability 259 265	stable
T31	Eq-Temporal-Period 346 353	ongoing
T32	Condition-Name 354 368	rhabdomyolysis
T33	Condition-Name 388 407	motor abnormalities
T34	Condition-Name 430 451	mitochondrial disease
T35	Eq-Operator 496 502	within
T36	Eq-Value 503 504	3
T37	Eq-Temporal-Unit 505 511	months
T38	Encounter-Type 532 544	Hospitalised
T39	Eq-Operator 545 551	within
T40	Eq-Value 552 553	3
T41	Eq-Temporal-Unit 554 560	months
T42	Severity 588 593	major
T43	Condition-Name 617 625	Pregnant
T44	Condition-Name 629 636	nursing
T45	Life-Stage-And-Gender 637 644	females
A1	Assertion-Type-Value E4 hypothetical
A5	Stability-Value T30 stable
A6	Eq-Temporal-Period-Value T31 present
A7	Eq-Operator-Value T35 LTEQ
A8	Eq-Temporal-Unit-Value T37 month
A9	Encounter-Type-Value T38 inpatient
A10	Eq-Operator-Value T39 LTEQ
A11	Eq-Temporal-Unit-Value T41 month
A12	Severity-Value T42 severe
A13	Life-Stage-And-Gender-Type T45 female
R1	Using Arg1:E13 Arg2:E15
R2	Treatment-For Arg1:E19 Arg2:E23
R3	If-Then Arg1:E26 Arg2:T45
R4	During Arg1:E5 Arg2:E7
R5	Before Arg1:E16 Arg2:E18
R6	Before Arg1:E20 Arg2:E22
R7	Or Arg1:E24 Arg2:E26
R8	And Arg1:E2 Arg2:E3
